BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 34752338)

  • 1. Interactions between noncoding RNAs as epigenetic regulatory mechanisms in cardiovascular diseases.
    Moukette B; Barupala NP; Aonuma T; Sepulveda M; Kawaguchi S; Kim IM
    Methods Cell Biol; 2021; 166():309-348. PubMed ID: 34752338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNAs in age-related cardiovascular diseases.
    Jusic A; Thomas PB; Wettinger SB; Dogan S; Farrugia R; Gaetano C; Tuna BG; Pinet F; Robinson EL; Tual-Chalot S; Stellos K; Devaux Y;
    Ageing Res Rev; 2022 May; 77():101610. PubMed ID: 35338919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy.
    Bär C; Chatterjee S; Thum T
    Circulation; 2016 Nov; 134(19):1484-1499. PubMed ID: 27821419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.
    Li Y; Huo C; Pan T; Li L; Jin X; Lin X; Chen J; Zhang J; Guo Z; Xu J; Li X
    Brief Bioinform; 2019 Jan; 20(1):66-76. PubMed ID: 28968629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNAs as a Diagnostic and Therapeutic Target in Cardiovascular Diseases.
    Joaquim VHA; Pereira NP; Fernandes T; Oliveira EM
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ncRNAs and polyphenols: new therapeutic strategies for hypertension.
    Shirazi-Tehrani E; Chamasemani A; Firouzabadi N; Mousaei M
    RNA Biol; 2022; 19(1):575-587. PubMed ID: 35438046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.
    Viereck J; Thum T
    Circ Res; 2017 Jan; 120(2):381-399. PubMed ID: 28104771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between ubiquitin ligases and ncRNAs drives cardiovascular disease progression.
    You JR; Wen ZJ; Tian JW; Lv XB; Li R; Li SP; Xin H; Li PF; Zhang YF; Zhang R
    Front Immunol; 2024; 15():1335519. PubMed ID: 38515760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA (Epi)genetics in cardiovascular diseases.
    Elia L; Condorelli G
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):11-6. PubMed ID: 26205296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding RNAs as Key Regulators for Cardiac Development and Cardiovascular Diseases.
    Kawaguchi S; Moukette B; Hayasaka T; Haskell AK; Mah J; Sepúlveda MN; Tang Y; Kim IM
    J Cardiovasc Dev Dis; 2023 Apr; 10(4):. PubMed ID: 37103045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short and Long Noncoding RNAs Regulate the Epigenetic Status of Cells.
    Uchida S; Bolli R
    Antioxid Redox Signal; 2018 Sep; 29(9):832-845. PubMed ID: 28847161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.
    Singh DD; Kim Y; Choi SA; Han I; Yadav DK
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction.
    Butler AA; Webb WM; Lubin FD
    Epigenomics; 2016 Jan; 8(1):135-51. PubMed ID: 26366811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding Competing Endogenous RNA Networks in Age-Associated Cardiovascular Diseases.
    Greco S; Gaetano C; Martelli F
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31238513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-coding RNA : Innovative regulators with therapeutic perspective].
    Bührke A; Bär C; Thum T
    Herz; 2018 Mar; 43(2):115-122. PubMed ID: 29236145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions Among Regulatory Non-coding RNAs Involved in Cardiovascular Diseases.
    Gabriel AF; Costa MC; Enguita FJ
    Adv Exp Med Biol; 2020; 1229():79-104. PubMed ID: 32285406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics meets epigenetics: Genetic variants that modulate noncoding RNA in cardiovascular diseases.
    Calore M; De Windt LJ; Rampazzo A
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):27-34. PubMed ID: 26546166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.
    Ao X; Ding W; Li X; Xu Q; Chen X; Zhou X; Wang J; Liu Y
    J Mol Med (Berl); 2023 May; 101(5):501-526. PubMed ID: 37014377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into circular RNAs: Biogenesis, function and their regulatory roles in cardiovascular disease.
    Ding C; Zhou Y
    J Cell Mol Med; 2023 May; 27(10):1299-1314. PubMed ID: 37002786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease.
    Zaiou M
    World J Gastroenterol; 2022 Sep; 28(35):5111-5128. PubMed ID: 36188722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.